A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home

Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families

The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.

Study Overview

• Status: Recruiting
• Conditions: Smoking; Smoking Cessation; Tobacco Use; Tobacco Smoking; Smoking Reduction; Smoking, Tobacco; Smoking, Cigarette; Smoking Behaviors; Smoking Habit; Smoking (Tobacco) Addiction
• Intervention / Treatment: Other: Indoor Air Quality Monitor AirGradient ONE

• Study Type: Interventional
• Enrollment (Estimated): 10
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Michael Bellamy, PhD; Phone Number: 212-639-2045; Email: bellamym@mskcc.org
• Study Contact Backup: Name: Gleneara Bates-Pappas, PhD, LMSW; Phone Number: 212-610-0507; Email: batespag@mskcc.org

Study Locations

• United States
  • New Jersey
    • Basking Ridge, New Jersey, United States, 07920
      • Recruiting
      • Memorial Sloan Kettering Basking Ridge (Consent Only)
      • Contact: Gleneara Bates-Pappas, PhD, LMSW; Phone Number: 212-610-0507
    • Middletown, New Jersey, United States, 07748
      • Recruiting
      • Memorial Sloan Kettering Monmouth (Consent Only)
      • Contact: Gleneara Bates-Pappas, PhD, LMSW; Phone Number: 212-610-0507
    • Montvale, New Jersey, United States, 07645
      • Recruiting
      • Memorial Sloan Kettering Bergen (Consent Only)
      • Contact: Gleneara Bates-Pappas, PhD, LMSW; Phone Number: 212-610-0507
  • New York
    • Commack, New York, United States, 11725
      • Recruiting
      • Memorial Sloan Kettering Suffolk-Commack (Consent only)
      • Contact: Gleneara Bates-Pappas, PhD, LMSW; Phone Number: 212-610-0507
    • Harrison, New York, United States, 10604
      • Recruiting
      • Memorial Sloan Kettering Westchester (Consent only)
      • Contact: Gleneara Bates-Pappas, PhD, LMSW; Phone Number: 212-610-0507
    • New York, New York, United States, 10065
      • Recruiting
      • Memorial Sloan Kettering Cancer Center (All Protocol Activities)
      • Contact: Gleneara Bates-Pappas, PhD,LMSW; Phone Number: 212-610-0507
    • New York, New York, United States, 10031
      • Not yet recruiting
      • City College of New York (Data Collection AND Data Analysis)
      • Contact: Prash Naidu, MD; Email: pnaidu@ccny.cuny.edu
    • Uniondale, New York, United States, 11553
      • Recruiting
      • Memorial Sloan Kettering Nassau (Consent Only)
      • Contact: Gleneara Bates-Pappas, PhD, LMSW; Phone Number: 212-610-0507

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Adult (aged >18 years) MSK patients as per the EHR
• Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database
• Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form
• Must be English-speaking in the EHR
• Must be reachable by phone as per self-report
• Must have Wi-Fi available at home as per self-report

Exclusion Criteria:

• Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: MSK Participants who are current smokers; 10 MSK participants who are current smokers and receiving tobacco treatment will be enrolled.

Other: Indoor Air Quality Monitor AirGradient ONE; Participants will be asked to set up an Indoor Air Quality Monitor AirGradient ONE (Model: I-9PSL) which is an award winning commercially available indoor air quality monitor designed to enable anyone to monitor their air quality in their home for about 60 days (8 weeks). Indoor air pollution levels within participating households will be measured using these AQMs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Percentage of participants using the air quality monitoring device for 14 consecutive days	Assess the feasibility and acceptability of collecting environmental data on biomarkers of household air quality (AQ) and smoke exposure using low-cost, AQMs as an intermediate endpoint of a smoke-free-home.	up to 8 weeks
Percentage of participants who attend the study-specific smoke-free workshop sessions	Assess the feasibility and acceptability of tobacco treatment adherence among individuals diagnosed with cancer.	Up to 8 weeks

Collaborators and Investigators

• Sponsor: Memorial Sloan Kettering Cancer Center
• Investigators: Principal Investigator: Gleneara Bates-Pappas, PhD, LMSW, Memorial Sloan Kettering Cancer Center

Publications and helpful links

Helpful Links

• Memorial Sloan Kettering Cancer Center

Study record dates

Study Major Dates

• Study Start (Actual): November 14, 2024
• Primary Completion (Estimated): November 14, 2027
• Study Completion (Estimated): November 14, 2027

Study Registration Dates

• First Submitted: November 14, 2024
• First Submitted That Met QC Criteria: November 14, 2024
• First Posted (Actual): November 18, 2024

Study Record Updates

• Last Update Posted (Estimated): October 22, 2025
• Last Update Submitted That Met QC Criteria: October 21, 2025
• Last Verified: October 1, 2025

More Information

Terms related to this study

• Keywords: smoking; smoking cessation; Memorial Sloan Kettering Cancer Center; smoking reduction; tobacco use; smoking behaviors; tobacco smoking; air quality; smoking, cigarette; smoking, tobacco; smoking habit; smoking (tobacco) addiction; indoor air quality monitoring devices; 24-260
• Additional Relevant MeSH Terms: Compulsive Behavior; Impulsive Behavior; Behavior; Health Behavior; Behavior, Addictive; Smoking; Smoking Cessation; Cigarette Smoking; Tobacco Use; Tobacco Smoking; Smoking Reduction
• Other Study ID Numbers: 24-260

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No